Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Biosyngen received FDA approval for Phase I/II Clinical Trials for BRL03, targeting Lung Cancer, Gastric Cancer and other advanced Solid Tumors 2023-09-11 14:53
Nobel Trust Family Joins BIOHK2023 - Unveiling Key Announcement 2023-09-08 16:30
Mabwell and WuXi XDC Sign Long-Term ADC Strategic Collaboration to Accelerate Global Layout of Innovative Biologics 2023-09-08 15:30
SIFI TO PRESENT NEW SCIENTIFIC DATA DURING THE 41ST CONGRESS OF THE EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS 2023-09-08 14:00
Adagene to Present at Investor and Scientific Conferences in September 2023-09-08 10:45
World Orphan Drug Alliance Welcomes Specialised Therapeutics 2023-09-08 04:00
SOAP Health and AESOP Technology Unite to Provide Advanced AI Solutions for Clinical Decision-Support and Medical Coding 2023-09-07 21:00
Australian Patient Advocacy Organization Named a Recipient of PTC Therapeutics' 2023 STRIVE™ Award for Duchenne Muscular Dystrophy 2023-09-07 20:00
Isotopia Issues a call to action to the radionuclide Therapy industry. 2023-09-06 20:40
Teikoku Pharma USA announces positive topline results from Phase 2 clinical trial of TPU-006, non- opioid pain management patch in Abdominoplasty Surgery. 2023-09-06 20:06
Gloria Biosciences Announces Zimberelimab Approved in China for the Treatment of Recurrent or Metastatic Cervical Cancer 2023-09-06 19:00
Brii Biosciences Announces Topline Interim Results of Phase 2 Study Evaluating BRII-179 (VBI-2601) in Combination with PEG-IFNα for the Treatment of Chronic Hepatitis B 2023-09-06 18:45
CANbridge to Participate in Two Investor Conferences in September 2023-09-06 16:06
Telix to Showcase New ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline at EANM 2023-09-06 14:18
MedAlliance announces enrollment of First Patient in SELUTION SLR LOVE-DEB Coronary Study 2023-09-06 08:00
MALAYSIA HEALTHCARE TRAVEL COUNCIL SELECTS MAYO CLINIC TO PROVIDE STRATEGIC COUNSEL TO FURTHER ADVANCE MEDICAL EXCELLENCE IN MALAYSIA 2023-09-05 22:37
YS Biopharma to Participate in Citi's 18th Annual Biopharma Conference 2023-09-05 20:30
Alteogen's Tergase® (Novel Recombinant Human Hyaluronidase Injection) Shows Excellent Immunogenicity Profile 2023-09-05 20:00
I-Mab Announces Upcoming Participation at September Conferences 2023-09-05 20:00
ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001 2023-09-05 14:00
1 81 82 83 84 85 413